Login
Navigate Fool.com

Biogen Idec

NASDAQ: BIIB

Community Rating: 4 Stars: Favorite

company name or ticker

Nasdaq 100 Movers: ILMN, YHOO

Monday's ETF Movers: FBT, GDX

3 Top Selling Drugs Investors Ought to Know About

Biogen (BIIB), Johnson & Johnson (JNJ) and Amgen (AMGN) all have fast growing drugs about to become blockbusters this year.

This Oral MS Drug Is Off to a Quick Start

Biogen Idec's Tecfidera is succeeding where Novartis and Sanofi struggled.

Can Biogen Catch up to Merck in Alzheimer's Race?

A collaboration pact with Eisai puts Biogen Idec right in the middle of a race to develop the first BACE inhibitor.

Catalysts That Could Push Top Biotech Stocks Even Higher

IBB, BIIB, AMGN, REGN: ETF Outflow Alert

Better Buy: Biogen Or Amgen?

Biogen (BIIB) and Amgen (AMGN) are biotech heavyweights hitting new highs. Is one a better buy than the other?

Nasdaq 100 Movers: BIIB, INTU

Why Sangamo Biosciences, Inc. Trounced the Market

Sangamo Biosciences shot up 20% today, but this may still be one to watch at a distance.
See More Articles...
Featured Broker Partners